Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
One year experience with erenumab: real-life data in 30 consecutive patients.
Ranieri A, Alfieri G, Napolitano M, Servillo G, Candelaresi P, Di Iorio W, Longo K, Maniscalco GT, Renna R, Rippa M, Salvatore S, Sagnelli A, Florio C, Manzo V. Ranieri A, et al. Among authors: maniscalco gt. Neurol Sci. 2020 Dec;41(Suppl 2):505-506. doi: 10.1007/s10072-020-04677-y. Neurol Sci. 2020. PMID: 32845486 No abstract available.
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients.
Bisecco A, Matrone F, Capobianco M, De Luca G, Filippi M, Granella F, Lus G, Marfia GA, Mirabella M, Patti F, Trojano M, Mascolo A, Copetti M, Tedeschi G, Gallo A; OCREVID study group on behalf of the Italian MS Register. Bisecco A, et al. J Neurol. 2024 Feb;271(2):699-710. doi: 10.1007/s00415-023-12084-4. Epub 2023 Nov 20. J Neurol. 2024. PMID: 37982852 Free PMC article.
[Registers as central real world data source: the experience of the Italian Multiple Sclerosis and Related Disorders Register].
Ponzio M, Battaglia MA, Trojano M, Salivetto M, D'Ettorre A, Corrado D, Paletta P, Lepore V, Mosconi P; Comitato Scientifico del Registro Italiano Sclerosi Multipla e Patologie Correlate; Rete dei centri del Registro Italiano Sclerosi Multipla e Patologie Correlate; Rete degli assistenti di ricerca del Registro Italiano Sclerosi Multipla e Patologie Correlate. Ponzio M, et al. Epidemiol Prev. 2024 Jul-Oct;48(4-5):361-374. doi: 10.19191/EP24.4-5.A734.074. Epidemiol Prev. 2024. PMID: 39329242 Free article. Italian.
Signs and symptoms of COVID-19 in patients with multiple sclerosis.
Schiavetti I, Carmisciano L, Ponzano M, Cordioli C, Cocco E, Marfia GA, Inglese M, Filippi M, Radaelli M, Bergamaschi R, Immovilli P, Capobianco M, De Rossi N, Brichetto G, Scandellari C, Cavalla P, Pesci I, Confalonieri P, Perini P, Trojano M, Lanzillo R, Tedeschi G, Comi G, Battaglia MA, Patti F, Salvetti M, Sormani MP; MuSC-19 Study Group. Schiavetti I, et al. Eur J Neurol. 2022 Dec;29(12):3728-3736. doi: 10.1111/ene.15554. Epub 2022 Sep 23. Eur J Neurol. 2022. PMID: 36086905 Free PMC article.
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy.
Totaro R, Lugaresi A, Bellantonio P, Danni M, Costantino G, Gasperini C, Florio C, Pucci E, Maddestra M, Spitaleri D, Lus G, Ardito B, Farina D, Rossi M, Di Carmine C, Altobelli E, Maccarone B, Casalena A, De Luca G, Travaglini D, Di Ioia M, Di Tommaso V, Fantozzi R, Ruggieri S, Provinciali L, De Riso S, Mundi C, Fuiani A, Galgani S, Ruggieri S, Maniscalco GT, Giuliani G, Cartechini E, Petretta V, Fratta M, Alfieri G, Gatto M, Carolei A; Natalizumab Long-Term Treatment Study group. Totaro R, et al. Among authors: maniscalco gt. Int J Immunopathol Pharmacol. 2014 Apr-Jun;27(2):147-54. doi: 10.1177/039463201402700201. Int J Immunopathol Pharmacol. 2014. PMID: 25004826 Free article.
The management of multiple sclerosis by reference centers in south of Italy: a 2011 survey on health demands and needs in Campania region.
de Waure C, Di Nardo F, Mazzucco W, Nedovic D, Battaglia MA, Busillo V, Di Iorio W, Gallo A, Lanzillo R, Lombardi E, Maniscalco GT, Orefice G, Petracca M, Romano F, Sinisi L, Spadera AP, Spitaleri D, Vivo P, Ricciardi W. de Waure C, et al. Among authors: maniscalco gt. Neurol Sci. 2016 Feb;37(2):315-22. doi: 10.1007/s10072-015-2389-5. Epub 2015 Oct 6. Neurol Sci. 2016. PMID: 26439919
Clinical predictors of Dimethyl Fumarate response in multiple sclerosis: a real life multicentre study.
Lanzillo R, Moccia M, Palladino R, Signoriello E, Carotenuto A, Maniscalco GT, Saccà F, Bonavita S, Russo CV, Iodice R, Petruzzo M, Sinisi L, De Angelis M, Lavorgna L, De Rosa A, Romano F, Orlando V, Ronga B, Florio C, Lus G, Brescia Morra V. Lanzillo R, et al. Among authors: maniscalco gt. Mult Scler Relat Disord. 2020 Feb;38:101871. doi: 10.1016/j.msard.2019.101871. Epub 2019 Nov 25. Mult Scler Relat Disord. 2020. PMID: 31786463
122 results